These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

566 related articles for article (PubMed ID: 30519867)

  • 21. EANM procedure guidelines for brain neurotransmission SPECT/PET using dopamine D2 receptor ligands, version 2.
    Van Laere K; Varrone A; Booij J; Vander Borght T; Nobili F; Kapucu OL; Walker Z; Någren K; Tatsch K; Darcourt J
    Eur J Nucl Med Mol Imaging; 2010 Feb; 37(2):434-42. PubMed ID: 19838704
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A brief review of Japanese guidelines for the clinical use of (18)F-FDG-PET/MRI 2012 (Ver 1.0).
    Kaneta T
    Ann Nucl Med; 2013 May; 27(4):309-13. PubMed ID: 23508379
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparison of 18F-FET PET and perfusion-weighted MR imaging: a PET/MR imaging hybrid study in patients with brain tumors.
    Filss CP; Galldiks N; Stoffels G; Sabel M; Wittsack HJ; Turowski B; Antoch G; Zhang K; Fink GR; Coenen HH; Shah NJ; Herzog H; Langen KJ
    J Nucl Med; 2014 Apr; 55(4):540-5. PubMed ID: 24578243
    [TBL] [Abstract][Full Text] [Related]  

  • 24. EANM procedure guidelines for brain neurotransmission SPECT using (123)I-labelled dopamine transporter ligands, version 2.
    Darcourt J; Booij J; Tatsch K; Varrone A; Vander Borght T; Kapucu OL; Någren K; Nobili F; Walker Z; Van Laere K
    Eur J Nucl Med Mol Imaging; 2010 Feb; 37(2):443-50. PubMed ID: 19838702
    [TBL] [Abstract][Full Text] [Related]  

  • 25. EANM practice guideline/SNMMI procedure standard for RAIU and thyroid scintigraphy.
    Giovanella L; Avram AM; Iakovou I; Kwak J; Lawson SA; Lulaj E; Luster M; Piccardo A; Schmidt M; Tulchinsky M; Verburg FA; Wolin E
    Eur J Nucl Med Mol Imaging; 2019 Nov; 46(12):2514-2525. PubMed ID: 31392371
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Imaging of amino acid transport in brain tumours: Positron emission tomography with O-(2-[
    Langen KJ; Stoffels G; Filss C; Heinzel A; Stegmayr C; Lohmann P; Willuweit A; Neumaier B; Mottaghy FM; Galldiks N
    Methods; 2017 Nov; 130():124-134. PubMed ID: 28552264
    [TBL] [Abstract][Full Text] [Related]  

  • 27. ¹¹C-methionine and ¹⁸F-fluorodeoxyglucose positron emission tomography/CT in the evaluation of patients with suspected primary and residual/recurrent gliomas.
    Li DL; Xu YK; Wang QS; Wu HB; Li HS
    Chin Med J (Engl); 2012 Jan; 125(1):91-6. PubMed ID: 22340472
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Usefulness of
    Somme F; Bender L; Namer IJ; Noël G; Bund C
    Cancer Imaging; 2020 Oct; 20(1):70. PubMed ID: 33023662
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Facts and Fictions About [
    Withofs N; Kumar R; Alavi A; Hustinx R
    PET Clin; 2022 Jul; 17(3):327-342. PubMed ID: 35717096
    [TBL] [Abstract][Full Text] [Related]  

  • 30. O-(2-18F-fluoroethyl)-L-tyrosine PET predicts failure of antiangiogenic treatment in patients with recurrent high-grade glioma.
    Hutterer M; Nowosielski M; Putzer D; Waitz D; Tinkhauser G; Kostron H; Muigg A; Virgolini IJ; Staffen W; Trinka E; Gotwald T; Jacobs AH; Stockhammer G
    J Nucl Med; 2011 Jun; 52(6):856-64. PubMed ID: 21622893
    [TBL] [Abstract][Full Text] [Related]  

  • 31. EANM procedure guideline for brain perfusion SPECT using 99mTc-labelled radiopharmaceuticals, version 2.
    Kapucu OL; Nobili F; Varrone A; Booij J; Vander Borght T; Någren K; Darcourt J; Tatsch K; Van Laere KJ
    Eur J Nucl Med Mol Imaging; 2009 Dec; 36(12):2093-102. PubMed ID: 19838703
    [TBL] [Abstract][Full Text] [Related]  

  • 32. (18)F-NaF PET/CT: EANM procedure guidelines for bone imaging.
    Beheshti M; Mottaghy FM; Paycha F; Behrendt FFF; Van den Wyngaert T; Fogelman I; Strobel K; Celli M; Fanti S; Giammarile F; Krause B; Langsteger W
    Eur J Nucl Med Mol Imaging; 2015 Oct; 42(11):1767-1777. PubMed ID: 26201825
    [TBL] [Abstract][Full Text] [Related]  

  • 33. PET-based response assessment criteria for diffuse gliomas (PET RANO 1.0): a report of the RANO group.
    Albert NL; Galldiks N; Ellingson BM; van den Bent MJ; Chang SM; Cicone F; de Groot J; Koh ES; Law I; Le Rhun E; Mair MJ; Minniti G; Rudà R; Scott AM; Short SC; Smits M; Suchorska B; Tolboom N; Traub-Weidinger T; Tonn JC; Verger A; Weller M; Wen PY; Preusser M
    Lancet Oncol; 2024 Jan; 25(1):e29-e41. PubMed ID: 38181810
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comment on: "FDG PET and PET/CT: EANM procedure guidelines for tumour PET imaging, version 1.0".
    Saboury B; Torigian DA; Alavi A
    Eur J Nucl Med Mol Imaging; 2010 Jul; 37(7):1430-1; author reply 1432-3. PubMed ID: 20503048
    [No Abstract]   [Full Text] [Related]  

  • 35. Guidelines for the use of 18F-FDG in infection and inflammation: a new step in cooperation between the EANM and SNMMI.
    Buscombe J
    Eur J Nucl Med Mol Imaging; 2013 Jul; 40(7):1120-1. PubMed ID: 23568088
    [No Abstract]   [Full Text] [Related]  

  • 36. Differentiating radiation necrosis from tumor recurrence in high-grade gliomas: assessing the efficacy of 18F-FDG PET, 11C-methionine PET and perfusion MRI.
    Kim YH; Oh SW; Lim YJ; Park CK; Lee SH; Kang KW; Jung HW; Chang KH
    Clin Neurol Neurosurg; 2010 Nov; 112(9):758-65. PubMed ID: 20619531
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The EANM-SNMMI guideline on the role of [18F]FDG-PET/CT in breast cancer: Important milestones and perspectives for the future.
    Hindié E
    Eur J Nucl Med Mol Imaging; 2024 Jul; 51(9):2695-2700. PubMed ID: 38735885
    [No Abstract]   [Full Text] [Related]  

  • 38. Novelties from the Joint EANM/SNMMI/ANZSNM Guidelines on Immunotherapy.
    Lopci E; Castello A; Filippi L
    Cancer Biother Radiopharm; 2023 May; 38(4):211-215. PubMed ID: 36730788
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Diagnostic accuracy of
    He Q; Zhang L; Zhang B; Shi X; Yi C; Zhang X
    BMC Cancer; 2019 Apr; 19(1):332. PubMed ID: 30961564
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Variability of [18F]FDG administered activities among patients undergoing PET examinations: an international multicenter survey.
    Del Sole A; Lecchi M; Lucignani G
    Radiat Prot Dosimetry; 2016 Mar; 168(3):337-42. PubMed ID: 25994847
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 29.